Foldax today announced one-year results from a clinical trial of its Tria polymer mitral heart valve offering.
In a trial based in India, the mitral valve demonstrated a good safety profile and sustained hemodynamic performance. Investigators reported a statistically significant improvement in patient quality of life.
“These results validate our st

Foldax presents positive polymer heart valve data

Despite worried hand-wringing over a potential slowdown in FDA approvals under the new administration, the agency has been giving the go-ahead to drugs at a near record-setting clip.
FDA approvals dropped in May to 14 drugs after hitting 20 and above in the two months prior, but the total of 84 OKs so far in 2025 is the second only to 2024’s record

3 of the year's most notable FDA nods

If you thought GLP-1 agonists were transformative - wait until you see what’s next.
The obesity drug market is exploding into a $100 billion opportunity, fuelled by breakthroughs in GLP-1 combinations, novel targets like GIPR modulators, and RNA-based therapies. However, with rapid innovation come critical challenges: efficacy gaps, lean mass prese

The Obesity Drug Development Summit has landed in Europe!

Boundaries aren’t a sign of weakness, but isolation is a fast-track to burnout. Gen-Z knows this.
One of the things I remind my clients of is this: You are not your work. Your value isn’t defined by a project or the decisions you make. When you conflate identity with output, you risk the pressure of perfectionism and burnout in the face of failure.

What Leaders Can Learn from Gen-Z and the Quiet Thriving Trend

Danaher (NYSE: DHR) announced today that it appointed a new chief technology and AI officer and a new EVP to lead Life Sciences.
The company chose Martin Stumpe to take on the role of chief technology and AI officer, effective Oct. 1, 2025. It selected Greg Milosevich to become EVP with responsibility for Life Sciences, effective July 1, 2025.
Stum

Danaher names new chief technology and AI officer, EVP for Life Sciences

Don’t miss the return of the Translational Digital Pathology & AI Summit, uniting 60+ leading biopharma pioneers driving the adoption and utilization of digital pathology, a technology that is set to change the course of patient diagnosis and treatment outcomes forever.
Key topics include:
Improving patient stratification
Real-time data analysis
De

2nd Translational Digital Pathology & AI Summit

Circa Scientific announced that it completed the limited market release for its CrossWise RF transseptal access system.
Englewood, Colorado-based Circa designed its zero-exchange RF system to deliver energy through a purpose-built cannula. The cannula maintains shape and stability during septal crossing. This approach allows for deliberate control

Circa completes limited launch of transseptal access system

The Neuropsychiatric Drug Development Summit returns for its eighth year as the industry’s flagship forum capturing advancements across discovery, preclinical, translational, clinical, and regulatory development of innovative neuropsychiatric therapeutics.
Over the 3-day agenda, you’ll join 150+ discovery, preclinical, translational, clinical, and

8th Neuropsychiatric Drug Development Summit

Moon Surgical this week announced it added three senior hires to its C-suite as the company accelerates the commercialization of its Maestro surgical assistant robot in the U.S. and Europe.
The company named Jonathan Conta chief marketing officer, Jeff Semone chief quality and regulatory officer, and Jeff Driggs vice president of U.S. sales. Conta

Moon Surgical adds to C-suite to support commercialization

with Dr. Sarah McKay
If you’ve ever felt like your brain is working against you, you’re not crazy, you’re not broken, and it’s not your fault.
Today, renowned neuroscientist Dr. Sarah McKay joins Mel to reveal the 3 factors that shape brain development, how female and male brains differ, and what’s really happening during PMS, pregnancy, and menopa

The Ultimate Guide to the Female Brain: Neuroscientist Reveals How to Boost Mood, Energy, & Focus

In early 2024, Gregory Cooke, then 27, had no intention of becoming the face of anything. Cooke had already experienced the highs and lows of entrepreneurship. A few years earlier, he had successfully run a digital agency with 42 employees, designing websites for clients across the UK. While the business was profitable, the pressure took a toll on

The Rise Of Six-Figure Faceless AI Video Creators

UCSF Health said it has laid off an estimated 200 employees in an effort to combat rising operating costs and lower reimbursements rates.
UnitedHealth Group names Patrick Conway CEO of Optum Health
Amar Desai had been CEO of Optum Health since 2023 and will become president of Optum integrated care and vice-chairman of Optum Health.

UCSF Health lays off 200 employees

Proposed funding cuts to the National Institutes of Health might not make a huge splash in biopharma right away, but industry leaders have expressed concern over potential ripples left in their wake.
As they stand currently, cuts by the Trump administration would lower the NIH budget in 2026 by about 40% to less than $28 billion, consolidating the

Biopharma is on edge about NIH funding cuts and what the future holds for research

Nektar Therapeutics has said phase 2b results show it was right to keep faith with rezpegaldesleukin as a therapy for atopic dermatitis (AD), also known as eczema.
Data from the REZOLVE-AD study of rezpegaldesleukin in moderate-to-severe AD showed significant improvements over placebo across a series of efficacy measures in the trial, and it now in

Nektar eyes pivotal trials for eczema drug cast off by Lilly

The FDA issued a notice identifying a high-risk device issue associated with a Medtronic recall of Bravo CF capsule delivery devices.
Medtronic and its Given Imaging subsidiary have issued two urgent medical device recalls to affected customers, with the first sent on June 3 and the second on June 16. The FDA issued its notice as part of a pilot to

FDA cites serious injuries associated with Medtronic Bravo CF capsule delivery devices

Robert F. Kennedy Jr.’s newly hand-picked panel of federal vaccine advisers met for the first time Wednesday since the Health and Human Services secretary abruptly fired their predecessors earlier this month.
While the advisers didn’t vote on any new recommendations, they probed aggressively into the evidence underpinning use of vaccines for COVID-

CDC panel, newly remade by RFK Jr., questions vaccine evidence

Scientists behind a study suggesting GSK's respiratory syncytial virus (RSV) vaccine could be protective against dementia have said the adjuvant used in the shot may be responsible.
The new observational study, carried out by the University of Oxford and funded by the UK government, found a 29% reduction in the risk of dementia in the 18 months aft

Could a vaccine adjuvant be protective against dementia?